余承佳;林泰誠YU, CHENG-CHIA;LIN, TAI-CHEN湯博軒TANG, PO-HSUANPO-HSUANTANG口腔科學研究所碩士班2026-01-092030-08-1420252025-06-27https://handle.ncl.edu.tw/11296/82dcsmhttps://scholars.csmu.edu.tw/handle/123456789/2893口腔黏膜炎是口腔癌患者接受放射治療後最常見且棘手的併發症,潰瘍、劇烈疼痛與吞嚥困難常迫使醫師中斷或延後治療,進一步影響預後。現行防護藥物價格高昂且副作用不可忽視,臨床多依賴止痛或抗發炎等支持性照護,但對症緩解效果有限,也無法真正預防放射線對口腔上皮造成的氧化壓力、後續發炎與凋亡反應。在不影響腫瘤控制的前提下如何同步保護正常口腔黏膜,仍是腫瘤放療領域急待解決的臨床難題。余甘子 (Phyllanthus emblica) 富含多酚,具備抗氧化、抗發炎與抗腫瘤等活性;體外與體內證據顯示,其能清除放射誘導過量活性氧及調節發炎串聯反應。但作為放射治療引發之口腔黏膜炎保護劑的臨床潛力,目前尚未有系統性之驗證。本研究首先以系列濃度對人類正常口腔上皮細胞與舌鱗狀上皮癌細胞進行研究,結果顯示余甘子萃取物對兩種細胞之半數抑制濃度分別為362.9 µg/mL與195 µg/mL,表明余甘子萃取物能在抑制腫瘤增殖的同時維持正常細胞存活。以低濃度余甘子萃取物預處理1小時後將正常口腔上皮細胞與舌癌細胞暴露於16 Gy放射線,以評估余甘子萃取物的放射保護功效。結果顯示,余甘子萃取物預處理雖未顯著改善放射引發的細胞凋亡與細胞週期G2期停滯,但以劑量依賴方式抑制super-G2細胞累積並減少活性氧生成;低濃度余甘子萃取物預處理顯著提升放射後正常上皮細胞活性及傷口癒合與遷移能力,同時提升抗氧化路徑Nrf2與下游HO-1之表現量並抑制發炎基因p65、IL-6與caspase 1表現量。另一方面,與單純放射處理相比,余甘子萃取物預處理可進一步降低舌癌細胞活性,表現出放射增敏潛力。整體而言,余甘子萃取物對正常口腔上皮細胞的放射保護,可能部分透過提升抗氧化能力、避免有絲分裂異常與多倍體形成而恢復細胞功能。並且除對正常口腔上皮細胞具有放射保護效果外,同時亦可提高腫瘤對放射治療的敏感性。Oral mucositis (OM) is the most common side effect experienced by oral cancer patients undergoing radiotherapy. Characterized by severe mucosal ulcerations, intense pain, and dysphagia, OM not only diminishes patient quality of life but also leads to treatment interruptions. Due to the high cost and significant side effects associated with current pharmacologic treatments, clinical management largely relies on supportive oral care. However, these approaches offer suboptimal symptom improvement, indicating the need for effective preventive and control strategies against radiation-induced OM. Phyllanthus emblica, a traditional herbal medicine, possesses diverse biological activities, including antioxidant, anti-inflammatory, and anti-cancer properties. Recent studies have further demonstrated its potential to mitigate radiation-induced epithelial damage. However, its precise role as a radioprotectant in the context of radiotherapy remains unexplored. Therefore, this study aimed to investigate the protective effect and underlying mechanisms of Phyllanthus emblica extract (PE) against radiation-induced damage of oral epithelial cells and OM. Initially, the cytotoxic effects of PE were evaluated on human normal oral epithelial cell line (SG) and oral squamous cell carcinoma cell line (SAS) across a range of concentrations. PE exhibited half-maximal inhibitory concentrations (IC50) of 362.9 µg/mL for normal oral epithelial cells and 195 µg/mL for oral squamous cell carcinoma cells, indicating that PE can reduce cell viability of SAS cells without significant damage to SG cells. To assess the radioprotective effect of PE, SG cells were pretreated with low concentrations (3.13, 6.25, and 12.5 µg/mL) of PE for 1 hour prior to a 16 Gy radiation exposure. Results demonstrated that PE pretreatment significantly enhanced the cell viability and wound healing capacity of irradiated SG cells. While PE did not prevent cells from radiation-induced apoptosis and cell cycle arrest, it dose-dependently suppressed radiation-induced super-G2 population and excessive reactive oxygen species production. Mechanistically, low-dose PE pretreatment upregulated the antioxidant Nrf2/HO-1 axis (protein level) while concomitantly suppressing the expression of inflammatory mediators p65, IL-6, and caspase-1 (mRNA level). Furthermore, PE pretreatment significantly enhanced the radiation-induced cytotoxicity in SAS cells. In summary, our findings suggest that the radioprotective effects of PE on normal oral epithelial cells may be partly mediated by enhancing cellular antioxidant capacity, thereby preventing mitotic abnormalities and polyploid formation, which subsequently restores cell viability and promotes wound healing. Moreover, beyond its radioprotective effects on normal oral epithelial cells, PE also demonstrates the ability to enhance the radiosensitivity of oral cancer cells.口腔黏膜炎口腔癌放射治療余甘子抗氧化放射保護oral mucositisoral cancerradiotherapyPhyllanthus emblicaantioxidantradioprotection探討余甘子萃取物對放射治療引起口腔上皮細胞損傷之 保護作用及分子機制thesis